Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Ajinomoto Althea Inc., a leading provider of biotherapeutic contract development and manufacturing services, today announced that the United States Patent and Trademark Office has issued US Patent 9,310,379 covering methods to crystallize monoclonal ...
read more
Tuesday, September 19, 2017
Ajinomoto Althea will soon open a GMP production suite in its newly constructed HPP commercial manufacturing facility located in San Diego.
read more
Tuesday, January 28, 2014
Ajinomoto Althea, Inc., a leading Contract Manufacturing Organization providing development and manufacturing services for biotechnology and pharmaceutical companies, announced today its new product offering, Corynex®, to produce secreted, soluble, ...
read more
Ajinomoto Althea announced that Bert Barbosa and Darwin Richardson, MBA, have joined Althea as Vice President of Drug Product Manufacturing and Vice President of Compliance, respectively.
read more
Wednesday, January 27, 2021
Ajinomoto Bio-Pharma Services and Humanigen will be expanding their manufacturing agreement for the fill finish supply of lenzilumab.
read more
Ajinomoto Bio-Pharma Services has entered into a manufacturing services agreement with CytoDyn for the supply of the investigational new drug, leronlimab.
read more
AIT Laboratories (AIT) has named Kun Ma, MD, Ph.D., MBA to the position of vice president of science and technology. Dr. Ma comes to the company after most recently serving as director of venture analysis at CHV Capital, Inc., and president and CEO ...
read more
Airway Therapeutics and Celonic Group announced a collaboration to produce the novel human recombinant protein AT-100 as a therapeutic candidate against COVID-19.
read more
Wednesday, January 10, 2018
Aimmune Therapeutics announced an expansion and extension of its exclusive supply agreement with Golden Peanut and Tree Nuts, to support AR101.
read more
AGU Planungsgesellschaft mbH and TetraScience have announced a new partnership to integrate their flagship products to automatically collect and unify R&D data in life sciences.
read more
Tuesday, January 15, 2019
AGC has entered into an agreement with Boehringer Ingelheim to acquire its subsidiary Malgrat Pharma Chemicals, S.L.U. (MPC).
read more
AGC has announced the completion of its acquisition of Spain's synthetic pharmaceutical active ingredient manufacturer, Malgrat Pharma Chemicals, S.L.U. (MPC).
read more
AGC Chemicals now offers small-molecule API contract manufacturing services.
read more
AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced its partnership with BioNTech SE (Nasdaq BNTX) to further supply Plasmid DNA (pDNA) starting material for the Pfizer-BioNTech ...
read more
AGC Biologics is partnering with clinical-stage biotech company Molecular Partners to develop a new class of custom-built protein therapeutics known as DARPin.
read more